Текст книги "COVID-19/SARS-CoV-2"

429. S Andonegui-Elguera, K Taniguchi-Ponciano, C R Gonzalez-Bonilla et al. Molecular Alterations Prompted by SARS-CoV-2 Infection: Induction of Hyaluronan, Glycosaminoglycan and Mucopolysaccharide Metabolism. Arch Med Res. 2020 Oct;51 (7):645—653. doi: 10.1016/j.arcmed.2020.06.011. Epub 2020 Jun 18.

430. N Kojima, N K Shrestha, J D Klausner. A Systematic Review of the Protective Effect of Prior SARS-CoV-2 Infection on Repeat Infection. Eval Health Prof. 2021 Dec;44 (4):327—332. doi: 10.1177/01632787211047932. Epub 2021 Sep 30.

431. S Gupta, M K Jawanda, N Taneja, T Taneja. A systematic review of Bell’s Palsy as the only major neurological manifestation in COVID-19 patients. J Clin Neurosci. 2021 Aug;90:284—292. doi: 10.1016/j.jocn.2021.06.016. Epub 2021 Jun 21.

432. K Choe, H Y Park, M Ikram et al. Systematic Review of the Common Pathophysiological Mechanisms in COVID-19 and Neurodegeneration: The Role of Bioactive Compounds and Natural Antioxidants. Cells. 2022 Apr 11;11 (8):1298. doi: 10.3390/cells11081298.

433. Y L Matos de Oliveira, A de Sá Resende, P R Martins-Filho, T Rodrigues de Moura. Role of triggering receptor expressed on myeloid cells-1 (TREM-1) in COVID-19 and other viral pneumonias: a systematic review and meta-analysis of clinical studies. Inflammopharmacology. 2022 Jun;30 (3):1037—1045. doi: 10.1007/s10787-022-00972-6. Epub 2022 Mar 28.

434. B Singh, M Gornet, H Sims et al. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its effect on gametogenesis and early pregnancy. Am J Reprod Immunol. 2020 Nov;84 (5):e13351. doi: 10.1111/aji.13351. Epub 2020 Oct 9.

435. J Y Kim, K Han, Y J Suh. Prevalence of abnormal cardiovascular magnetic resonance findings in recovered patients from COVID-19: a systematic review and meta-analysis. J Cardiovasc Magn Reson. 2021 Sep 3;23 (1):100. doi: 10.1186/s12968-021-00792-7.

436. F Yusuf, M Fahriani, Sukamto S Mamada et al. Global prevalence of prolonged gastrointestinal symptoms in COVID-19 survivors and potential pathogenesis: A systematic review and meta-analysis. F1000Res. 2021 Apr 19;10:301. doi: 10.12688/f1000research.52216.1. eCollection 2021.

437. A Zinellu, A A Mangoni. Serum Complement C3 and C4 and COVID-19 Severity and Mortality: A Systematic Review and Meta-Analysis With Meta-Regression. Front Immunol. 2021 Jun 7;12:696085. doi: 10.3389/fimmu.2021.696085. eCollection 2021.

438. N Parsons, A Outsikas, A Parish et al. Modelling the Anatomical Distribution of Neurological Events in COVID-19 Patients: A Systematic Review. medRxiv. 2020 Oct 23;2020.10.21.20215640. doi: 10.1101/2020.10.21.20215640. Preprint. Data di accesso: 23.01.23.

439. A K G Melo, K M Milby, A L M A Caparroz et al. Biomarkers of cytokine storm as red flags for severe and fatal COVID-19 cases: A living systematic review and meta-analysis. PLoS One. 2021 Jun 29;16 (6):e0253894. doi: 10.1371/journal. pone.0253894. eCollection 2021.

440. K I Notarte, J A Catahay, J V Velasco et al. Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review. EClinicalMedicine. 2022 Aug 27;53:101624. doi: 10.1016/j.eclinm.2022.101624. eCollection 2022 Nov.

441. S Alhumaid, A Al Mutair, J S Busubaih et al. Colorectal cancer in patients with SARS-CoV-2: a systematic review and meta-analysis. Infect Agent Cancer. 2022 Sep 12;17 (1):49. doi: 10.1186/s13027-022-00459-7.

442. A Patrizio, S Martina Ferrari, G Elia et al. Graves’ Disease Following SARS-CoV-2 Vaccination: A Systematic Review. Vaccines (Basel). 2022 Sep 1;10 (9):1445. doi: 10.3390/vaccines10091445.

443. D R Feikin, M M Higdon, Laith J Abu-Raddad et al. Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression. Lancet. 2022 Mar 5;399 (10328):924—944. doi: 10.1016/S0140—6736 (22) 00152—0. Epub 2022 Feb 23.

444. B Zeng, L Gao, Q Zhou et al. Effectiveness of COVID-19 vaccines against SARS-CoV-2 variants of concern: a systematic review and meta-analysis. BMC Med. 2022 May 23;20 (1):200. doi: 10.1186/s12916-022-02397-y.

445. G Avallone, P Quaglino, F Cavallo et al. SARS-CoV-2 vaccine-related cutaneous manifestations: a systematic review. Int J Dermatol. 2022 Oct;61 (10):1187—1204. doi: 10.1111/ijd.16063. Epub 2022 Feb 9.

446. L Deng, P Li, X Zhang et al. Risk of SARS-CoV-2 reinfection: a systematic review and meta-analysis. Sci Rep. 2022 Dec 1;12 (1):20763. doi: 10.1038/s41598-022-24220-7.

447. K Tao, P L Tzou, S L Kosakovsky Pond et al. Susceptibility of SARS-CoV-2 Omicron Variants to Therapeutic Monoclonal Antibodies: Systematic Review and Meta-analysis. Microbiol Spectr. 2022 Aug 31;10 (4):e0092622. doi: 10.1128/spectrum.00926—22. Epub 2022 Jun 14.

448. M J Abrahão Silva, Y C Rodrigues, K V Batista Lima, et al. Innate immunity to SARS-CoV-2 infection: a review. Epidemiol Infect. 2022 Jul 18;150:e142. doi: 10.1017/S095026882200125X.

449. S Benvari, S Mahmoudi, M Mohammadi. Gastrointestinal viral shedding in children with SARS-CoV-2: a systematic review and meta-analysis. World J Pediatr. 2022 Sep;18 (9):582—588. doi: 10.1007/s12519-022-00553-1. Epub 2022 Jun 4.

450. S Sen, N B Kannan, J Kumar et al. Retinal manifestations in patients with SARS-CoV-2 infection and pathogenetic implications: a systematic review. Int Ophthalmol. 2022 Jan;42 (1):323—336. doi: 10.1007/s10792-021-01996-7. Epub 2021 Aug 11.

451. T Abrehart, R Suryadinata, C McCafferty et al. Age-related differences in SARS-CoV-2 binding factors: An explanation for reduced susceptibility to severe COVID-19 among children? Paediatr Respir Rev. 2022 Dec;44:61—69. doi: 10.1016/j.prrv.2022.01.008. Epub 2022 Feb 8.

452. R Martinez-Reviejo, S Tejada, A Cipriano et al. Solid organ transplantation from donors with recent or current SARS-CoV-2 infection: A systematic review. Anaesth Crit Care Pain Med. 2022 Aug;41 (4):101098. doi: 10.1016/j.accpm.2022.101098. Epub 2022 May 6.

453. Min Du, Yirui Ma, Jie Deng et al. Comparison of Long COVID-19 Caused by Different SARS-CoV-2 Strains: A Systematic Review and Meta-Analysis. Int J Environ Res Public Health. 2022 Nov 30;19 (23):16010. doi: 10.3390/ijerph192316010.

454. N N Y Tsang, H Chi So, B J Cowling et al. Performance of saline and water gargling for SARS-CoV-2 reverse transcriptase PCR testing: a systematic review and meta-analysisEur Respir Rev. 2022 Sep 20;31 (165):220014. doi: 10.1183/16000617.0014—2022. Print 2022 Sep 30.

455. S Chowdhury, Md Shahraj Chowdhury, N S Chowdhury et al. Omicron variant of SARS-CoV-2 infection elicits cross-protective immunity in people who received boosters or infected with variant strains. Int J Immunopathol Pharmacol. 2022 Jan-Dec;36:3946320221133001. doi: 10.1177/03946320221133001.

456. F Xiao, M Tang, K Yan, W Zhou. Clinical features of infants with SARS-CoV-2 infection: a systematic review and meta-analysis. Ann Palliat Med. 2022 Nov;11 (11):3394—3408. doi: 10.21037/apm-22-933. Epub 2022 Oct 31.

457. J H Choi, Soo-Han Choi, K W Yun. Risk Factors for Severe COVID-19 in Children: A Systematic Review and Meta-Analysis. J Korean Med Sci. 2022 Feb 7;37 (5):e35. doi: 10.3346/jkms.2022.37.e35.

458. W Morello, F A Vianello, E Proverbio et al. COVID-19 and idiopathic nephrotic syndrome in children: systematic review of the literature and recommendations from a highly affected area. Pediatr Nephrol. 2022 Apr;37 (4):757—764. doi: 10.1007/s00467-021-05330-2. Epub 2021 Oct 23.

459. J Bao, Z Guo, J He et al. Semen parameters and sex hormones as affected by SARS-CoV-2 infection: A systematic review. Prog Urol. 2022 Dec;32 (16):1431—1439. doi: 10.1016/j. purol.2022.09.004. Epub 2022 Sep 13.

460. K Jenniskens, M C J Bootsma, J A A G Damen et al. Effectiveness of contact tracing apps for SARS-CoV-2: a rapid systematic review. BMJ Open. 2021 Jul 12;11 (7):e050519. doi: 10.1136/bmjopen-2021-050519.

461. Z Du, C Liu, C Wang et al. Reproduction Numbers of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants: A Systematic Review and Meta-analysis. Clin Infect Dis. 2022 Aug 24;75 (1):e293-e295. doi: 10.1093/cid/ciac137.

462. A J Gadenstaetter, C D Mayer, L D Landegger. Nasopharyngeal versus nasal swabs for detection of SARS-CoV-2: a systematic review. Rhinology 2021 Oct 1;59 (5):410—421. doi: 10.4193/Rhin21.162.

463. F. Marzoli, A. Bortolami, A. Pezzuto et al. A systematic review of human coronaviruses survival on environmental surfaces. Sci Total Environ. 2021 Jul 15;778:146191. doi: 10.1016/j.scitotenv.2021.146191. Epub 2021 Mar 3.

464. R Yeahia, J. Schefflein, P. Chiarolanzio et al. Brain MRI findings in COVID-19 patients with PRES: A systematic review. Clin Imaging. 2022 Jan;81:107—113. doi: 10.1016/j.clinimag.2021.10.003. Epub 2021 Oct 16.

465. M Rahmati, A Koyanagi, E Banitalebi et al. The effect of SARS-CoV-2 infection on cardiac function in post-COVID-19 survivors: A systematic review and meta-analysis. J Med Virol. 2023 Jan;95 (1):e28325. doi: 10.1002/jmv.28325.

466. M. Russo, D. Calisi, M. A De Rosa et al. COVID-19 and first manic episodes: a systematic review. Psychiatry Res. 2022 Aug;314:114677. doi: 10.1016/j.psychres.2022.114677. Epub 2022 Jun 9.

467. A Almazroa, S Alamri, B Alabdulkader et al. Ocular transmission and manifestation for coronavirus disease: a systematic review. Int Health. 2022 Mar 2;14 (2):113—121. doi: 10.1093/inthealth/ihab028.

468. D. Ligi, R. V. Giglio, Brandon M Henry et al. What is the impact of circulating histones in COVID-19: a systematic review. Clin Chem Lab Med. 2022 Jul 19;60 (10):1506—1517. doi: 10.1515/cclm-2022-0574. Print 2022 Sep 27.

469. Z Li, X Li, J Shen et al. Miller Fisher syndrome associated with COVID-19: an up-to-date systematic review. Environ Sci Pollut Res Int. 2021 May;28 (17):20939—20944. doi: 10.1007/s11356-021-13233-w. Epub 2021 Mar 6.

470. I Elmakaty, K Ferih, O Karen et al. Clinical Implications of COVID-19 Presence in CSF: Systematic Review of Case Reports. Cells. 2022 Oct 13;11 (20):3212. doi: 10.3390/cells11203212.

471. E Drzymalla, R Fisk Green, M Knuth et al. COVID-19-related health outcomes in people with primary immunodeficiency: A systematic review. Clin Immunol. 2022 Oct;243:109097. doi: 10.1016/j.clim.2022.109097. Epub 2022 Aug 13.

472. Z Sadiq, S Rana, Z Mahfoud et al. Systematic review and meta-analysis of chest radiograph (CXR) findings in COVID-19. Clin Imaging. 2021 Dec;80:229—238. doi: 10.1016/j.clinimag.2021.06.039. Epub 2021 Jul 27.

473. Z Du, H Hong, S Wang et al. Reproduction Number of the Omicron Variant Triples That of the Delta Variant.Viruses. 2022 Apr 15;14 (4):821. doi: 10.3390/v14040821.

474. X Zhang, X Ge, F Shen et al. Diagnostic efficiency of RPA/RAA integrated CRISPR-Cas technique for COVID-19: A systematic review and meta-analysis. PLoS One. 2022 Oct 26;17 (10):e0276728. doi: 10.1371/journal. pone.0276728. eCollection 2022.

475. K G Raviraj, S S Shobhana. Findings and inferences from full autopsies, minimally invasive autopsies and biopsy studies in patients who died as a result of COVID19 – A systematic review. Forensic Sci Med Pathol. 2022 Sep;18 (3):369—381. doi: 10.1007/s12024-022-00494-1. Epub 2022 Jul 8.

476. H Raj Mutneja, A Bhurwal, S Arora et al. Acute pancreatitis in patients with COVID-19 is more severe and lethal: a systematic review and meta-analysis. Scand J Gastroenterol. 2021 Dec;56 (12):1467—1472. doi: 10.1080/00365521.2021.1971757. Epub 2021 Aug 31.

477. G S Rahman, A A N Alshetan, S S O Alotaibi et al. Is chlorhexidine mouthwash effective in lowering COVID-19 viral load? A systematic review. Eur Rev Med Pharmacol Sci. 2023 Jan;27 (1):366—377. doi: 10.26355/eurrev_202301_30890.

478. G W K Duarsa, R Sugianto, I G A A A Yusari et al. Predictor factor for worse outcomes in kidney transplant recipients infected with coronavirus disease 2019: A systematic review and meta-analysis. Transpl Immunol. 2023 Feb;76:101739. doi: 10.1016/j.trim.2022.101739. Epub 2022 Nov 19.

479. R B Hawkins, J HMehaffey, E J Charles et al. Lung Transplantation for Severe Post-coronavirus Disease 2019 Respiratory Failure. Transplantation. 2021 Jun 1;105 (6):1381—1387. doi: 10.1097/TP.0000000000003706.

480. E D Batu, S Sener, S Ozen. COVID-19 associated pediatric vasculitis: A systematic review and detailed analysis of the pathogenesis. Seminars in Arthritis and Rheumatism. Volume 55, August 2022, 152047. https://doi.org/10.1016/j.semarthrit.2022.152047.

481. M Petráš. Highly Effective Naturally Acquired Protection Against COVID-19 Persists for at Least 1 Year: A Meta-Analysis. J Am Med Dir Assoc. 2021 Nov;22 (11):2263—2265. doi: 10.1016/j. jamda.2021.08.042. Epub 2021 Sep 16.

482. N S Scheiner, A K Smith, M Wohlleber et al. COVID-19 and Catatonia: A Case Series and Systematic Review of Existing Literature. J Acad Consult Liaison Psychiatry. 2021 Nov-Dec;62 (6):645—656. doi: 10.1016/j. jaclp.2021.04.003. Epub 2021 Apr 20.

483. U Anand, X Li, K Sunita et al. SARS-CoV-2 and other pathogens in municipal wastewater, landfill leachate, and solid waste: A review about virus surveillance, infectivity, and inactivation. Environ Res. 2022 Jan;203:111839. doi: 10.1016/j. envres.2021.111839. Epub 2021 Aug 4.

484. W Yu, Y Guo, S Zhang et al. Proportion of asymptomatic infection and nonsevere disease caused by SARS-CoV-2 Omicron variant: A systematic review and analysis. J Med Virol. 2022 Dec;94 (12):5790—5801. doi: 10.1002/jmv.28066. Epub 2022 Aug 24.

485. Yu Wu, L Kang, Z Guo et al. Incubation Period of COVID-19 Caused by Unique SARS-CoV-2 Strains: A Systematic Review and Meta-analysis. JAMA Netw Open. 2022 Aug 1;5 (8):e2228008. doi: 10.1001/jamanetworkopen.2022.28008.

486. R Conway, A A Grimshaw, M F Konig et al. SARS-CoV-2 Infection and COVID-19 Outcomes in Rheumatic Diseases: A Systematic Literature Review and Meta-Analysis. Arthritis Rheumatol. 2022 May;74 (5):766—775. doi: 10.1002/art.42030. Epub 2022 Mar 28.

487. E R Smith, E Oakley, G Wable Grandner et al. Adverse maternal, fetal, and newborn outcomes among pregnant women with SARS-CoV-2 infection: an individual participant data meta-analysis. BMJ Glob Health. 2023 Jan;8 (1):e009495. doi: 10.1136/bmjgh-2022-009495.

488. G Corona, W Vena, A Pizzocaro et al. Andrological effects of SARS-Cov-2 infection: a systematic review and meta-analysis. J Endocrinol Invest. 2022 Dec;45 (12):2207—2219. doi: 10.1007/s40618-022-01801-x. Epub 2022 May 9.

489. D Lazaridis, S Leung, L Kohler et al. The Impact of Anticoagulation on COVID-19 (SARS CoV-2) Patient Outcomes: A Systematic Review. J Pharm Pract. 2022 Dec;35 (6):1000—1006. doi: 10.1177/08971900211015055. Epub 2021 May 7.

490. A R Antony, Z Haneef. Systematic review of EEG findings in 617 patients diagnosed with COVID-19. Seizure. 2020 Dec;83:234—241. doi: 10.1016/j.seizure.2020.10.014. Epub 2020 Oct 19.

491. M-T Holzer, M Krusche, N Ruffer et al. New-onset dermatomyositis following SARS-CoV-2 infection and vaccination: a case-based review. Rheumatol Int. 2022 Dec;42 (12):2267—2276. doi: 10.1007/s00296-022-05176-3. Epub 2022 Aug 8.

492. K Musacchio Schafer, A Lieberman, A C Sever, T Joiner. Prevalence rates of anxiety, depressive, and eating pathology symptoms between the pre– and peri-COVID-19 eras: A meta-analysis. J Affect Disord. 2022 Feb 1;298 (Pt A):364—372. doi: 10.1016/j. jad.2021.10.115. Epub 2021 Nov 3.

493. B Fazzini, D Battaglini, L Carenzo et al. Physical and psychological impairment in survivors of acute respiratory distress syndrome: a systematic review and meta-analysis. Br J Anaesth. 2022 Nov;129 (5):801—814. doi: 10.1016/j.bja.2022.08.013. Epub 2022 Aug 26.

494. D The Hung, S Ghula, J Muhamad Abdul Aziz et al. The efficacy and adverse effects of favipiravir on patients with COVID-19: A systematic review and meta-analysis of published clinical trials and observational studies. Int J Infect Dis. 2022 Jul;120:217—227. doi: 10.1016/j. ijid.2022.04.035. Epub 2022 Apr 22.

495. R Marcec, V M Dodig, I Radanovic, R Likic. Intravenous immunoglobulin (IVIg) therapy in hospitalised adult COVID-19 patients: A systematic review and meta-analysis. Rev Med Virol. 2022 Nov;32 (6):e2397. doi: 10.1002/rmv.2397. Epub 2022 Sep 12.

496. G Carpenè, D Negrini, B M Henry et al. Homocysteine in coronavirus disease (COVID-19): a systematic literature review. Diagnosis (Berl). 2022 Jun 16;9 (3):306—310. doi: 10.1515/dx-2022-0042. eCollection 2022 Aug 1.

497. J S K Teh, J Coussement, Z C F Neoh et al. Immunogenicity of COVID-19 vaccines in patients with hematologic malignancies: a systematic review and meta-analysis. Blood Adv. 2022 Apr 12;6 (7):2014—2034. doi: 10.1182/bloodadvances.2021006333.

498. Y Du, L Chen, Y Shi. Booster COVID-19 vaccination against the SARS-CoV-2 Omicron variant: A systematic review. Hum Vaccin Immunother. 2022 Nov 30;18 (5):2062983. doi: 10.1080/21645515.2022.2062983. Epub 2022 May 2.

499. Q Wang, R Huang. The impact of COVID-19 pandemic on sustainable development goals – A surveyEnviron Res. 2021 Nov;202:111637. doi: 10.1016/j. envres.2021.111637. Epub 2021 Jul 4.

500. P R Martins-Filho, E Marques do Nascimento-Júnior, J A Barreto-Alves et al. Efficacy and safety of nitazoxanide in treating SARS-CoV-2 infection: a systematic review and meta-analysis of blinded, placebo-controlled, randomized clinical trials. Eur J Clin Pharmacol. 2022 Nov;78 (11):1813—1821. doi: 10.1007/s00228-022-03380-5. Epub 2022 Sep 6.

501. M H de Las Casas Lima, A L Brusiquesi Cavalcante, SCorreia Leão. Pathophysiological relationship between COVID-19 and olfactory dysfunction: A systematic review. Braz J Otorhinolaryngol. 2022 Sep-Oct;88 (5):794—802. doi: 10.1016/j.bjorl.2021.04.001. Epub 2021 Apr 25.

502. H Krumbein, L S Kümmel, P C Fragkou et al. Respiratory viral co-infections in patients with COVID-19 and associated outcomes: A systematic review and meta-analysis. Rev Med Virol. 2023 Jan;33 (1):e2365. doi: 10.1002/rmv.2365. Epub 2022 Jun 10.

503. S Soni, R N Pudake, U Jain, NChauhan. A systematic review on SARS-CoV-2-associated fungal coinfections. J Med Virol. 2022 Jan;94 (1):99—109. doi: 10.1002/jmv.27358. Epub 2021 Oct 5.

504. M Liu, H Wang, L Liu et al. Risk of COVID-19 infection, hospitalization and mortality in psoriasis patients treated with interleukin-17 inhibitors: A systematic review and meta-analysis. Front Immunol. 2022 Oct 21;13:1046352. doi: 10.3389/fimmu.2022.1046352. eCollection 2022.

505. A I Franco-Moreno, A Bustamante-Fermosel, J M Ruiz-Giardin et al. Utility of probability scores for the diagnosis of pulmonary embolism in patients with SARS-CoV-2 infection: A systematic review. Rev Clin Esp (Barc). 2023 Jan;223 (1):40—49. doi: 10.1016/j. rceng.2022.07.004. Epub 2022 Sep 22.

506. T Stephenson, R Shafran, S N Ladhani. Long COVID in children and adolescents. Curr Opin Infect Dis. 2022 Oct 1;35 (5):461—467. doi: 10.1097/QCO.0000000000000854. Epub 2022 Aug 3.

507. A M Isidori, E Giannetta, R Pofi et al. Targeting the NO-cGMP-PDE5 pathway in COVID-19 infection. The DEDALO project. Andrology. 2021 Jan;9 (1):33—38. doi: 10.1111/andr.12837. Epub 2020 Jul 3.

508. T S Omolaoye, PA Velilla, J S Moncada López et al. SARS-CoV-2 Vaccine Effects on Semen Parameters: A Systematic Review and Meta-Analysis. Arch Esp Urol. 2022 Dec;75 (10):831—843. doi: 10.56434/j.arch.esp. urol.20227510.121.

509. J Finsterer, F A Scorza, C Scorza, A Fiorini. COVID-19 associated cranial nerve neuropathy: A systematic review. Bosn J Basic Med Sci. 2022 Feb 1;22 (1):39—45. doi: 10.17305/bjbms.2021.6341.

510. O Mirmosayyeb, E MGhaffary, S Bagherieh et al. Post COVID-19 infection neuromyelitis optica spectrum disorder (NMOSD): A case report-based systematic review. Mult Scler Relat Disord. 2022 Apr;60:103697. doi: 10.1016/j.msard.2022.103697. Epub 2022 Feb 19.

511. L Zhang, C Tang, M Zhang et al. Single cell meta-analysis of EndMT and EMT state in COVID-19. Front Immunol. 2022 Sep 29;13:976512. doi: 10.3389/fimmu.2022.976512. eCollection 2022.

512. H-L Li, B-Y Yang, L-J Wang et al. A meta-analysis result: Uneven influences of season, geo-spatial scale and latitude on relationship between meteorological factors and the COVID-19 transmission. Environ Res. 2022 Sep;212 (Pt B):113297. doi: 10.1016/j. envres.2022.113297. Epub 2022 Apr 15.

513. N Carlson, W M Szpirt. Use of therapeutic plasma exchange in COVID-19: A systematic review of current evidence. Ther Apher Dial. 2022 Dec;26 Suppl 1:3—11. doi: 10.1111/1744—9987.13779. Epub 2022 Dec 5.

514. K Tsamakis, D Tsiptsios, B Stubbs et al. Summarising data and factors associated with COVID-19 related conspiracy theories in the first year of the pandemic: a systematic review and narrative synthesis. BMC Psychol. 2022 Nov 1;10 (1):244. doi: 10.1186/s40359-022-00959-6.

515. C Yan, Y Chen, C Sun et al. Does Proton Pump Inhibitor Use Lead to a Higher Risk of Coronavirus Disease 2019 Infection and Progression to Severe Disease? a Meta-analysis. Jpn J Infect Dis. 2022 Jan 24;75 (1):10—15. doi: 10.7883/yoken. JJID.2021.074. Epub 2021 May 31.

516. I Bergeri, M G Whelan, H Ware et al. Global SARS-CoV-2 seroprevalence from January 2020 to April 2022: A systematic review and meta-analysis of standardized population-based studies. PLoS Med. 2022 Nov 10;19 (11):e1004107. doi: 10.1371/journal.pmed.1004107. eCollection 2022 Nov.

517. Zein AFMZ, Raffaello WM. Dipeptidyl peptidase-4 (DPP-IV) inhibitor was associated with mortality reduction in COVID-19 – A systematic review and meta-analysis. Prim Care Diabetes. 2022 Feb;16 (1):162—167. doi: 10.1016/j. pcd.2021.12.008.

518. L Chen, K Hu, C Cheng et al. Risk of adverse outcomes in inflammatory bowel disease patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Colorectal Dis. 2022 Nov;37 (11):2277—2289. doi: 10.1007/s00384-022-04265-w. Epub 2022 Oct 22.

519. D McConnell, M Harte, C Walsh et al. Comparative effectiveness of neutralising monoclonal antibodies in high risk COVID-19 patients: a Bayesian network meta-analysis. Sci Rep. 2022 Oct 20;12 (1):17561. doi: 10.1038/s41598-022-22431-6.

520. F Degenhardt, D Ellinghaus, S Juzenas et al. Detailed stratified GWAS analysis for severe COVID-19 in four European populations. Hum Mol Genet. 2022 Nov 28;31 (23):3945—3966. doi: 10.1093/hmg/ddac158.

521. L Ayerbe, C Risco-Risco, I Forgnone et al. Azithromycin in patients with COVID-19: a systematic review and meta-analysis. J Antimicrob Chemother. 2022 Feb 2;77 (2):303—309. doi: 10.1093/jac/dkab404.

522. Md A Aziz, M S Islam. Association of ACE1 I/D rs1799752 and ACE2 rs2285666 polymorphisms with the infection and severity of COVID-19: A meta-analysis. Mol Genet Genomic Med. 2022 Nov;10 (11):e2063. doi: 10.1002/mgg3.2063. Epub 2022 Sep 23.

523. A Faridzadeh, M Mahmoudi et al. The role of ACE1 I/D and ACE2 polymorphism in the outcome of Iranian COVID-19 patients: A case-control study. Front. Genet., 05 September 2022 Sec. Human and Medical Genomics Volume 13 – 2022 | ttps://doi.org/10.3389/fgene.2022.955965.

524. M S Durstenfeld, K Sun, P Tahir et al. Use of Cardiopulmonary Exercise Testing to Evaluate Long COVID-19 Symptoms in Adults: A Systematic Review and Meta-analysis. JAMA Netw Open. 2022 Oct 3;5 (10):e2236057. doi: 10.1001/jamanetworkopen.2022.36057.

525. T Uddin, N Siddiquee, M N Khandaker et al. Efficacy and Safety of the Awake Prone Positioning in Patients with COVID-19 Related Respiratory Distress: A Scoping Review. Mymensingh Med J. 2022 Jan;31 (1):272—279.

526. R Di Girolamo, A Khalil, G Rizzo et al. Systematic review and critical evaluation of quality of clinical practice guidelines on the management of SARS-CoV-2 infection in pregnancy. Am J Obstet Gynecol MFM. 2022 Sep;4 (5):100654. doi: 10.1016/j. ajogmf.2022.100654. Epub 2022 May 2.

527. N-G Manolache, G Mjaess, R Diamand et al. [Prostate cancer, androgen deprivation, and risk of COVID-19 infection: A systematic review and meta-analysis] [Article in French]. Prog Urol. 2022 Dec;32 (16):1421—1430. doi: 10.1016/j. purol.2022.09.005. Epub 2022 Sep 13.

528. J M Low, Y W Low, Y Zhong et al. Titres and neutralising capacity of SARS-CoV-2-specific antibodies in human milk: a systematic review. Arch Dis Child Fetal Neonatal Ed. 2022 Mar;107 (2):174—180. doi: 10.1136/archdischild-2021-322156. Epub 2021 Jul 13.

529. R B M Landewé, F P B Kroon, A Alunno et al. EULAR recommendations for the management and vaccination of people with rheumatic and musculoskeletal diseases in the context of SARS-CoV-2: the November 2021 update. Ann Rheum Dis. 2022 Dec;81 (12):1628—1639. doi: 10.1136/annrheumdis-2021-222006. Epub 2022 Feb 23.

530. Wen-Ting Li, Y Zhang, M Liu et al. Prolonged viral shedding in feces of children with COVID-19: a systematic review and synthesis of data. Eur J Pediatr. 2022 Dec;181 (12):4011—4017. doi: 10.1007/s00431-022-04622-5. Epub 2022 Sep 17.

531. S D Alipoor, M Mirsaeidi. SARS-CoV-2 cell entry beyond the ACE2 receptor. Mol Biol Rep. 2022 Nov;49 (11):10715—10727. doi: 10.1007/s11033-022-07700-x. Epub 2022 Jun 26.

532. M Afraie, G Moradi, P Mohammadzedeh et al. COVID-19 and Parkinson’s disease: a systematic review and meta-analysis. Acta Neurol Belg. 2022 Nov 16;1—15. doi: 10.1007/s13760-022-02141-6. Online ahead of print.

533. S S Ali, A Mumtaz, M A Qamar et al. New-onset Parkinsonism as a Covid-19 infection sequela: A systematic review and meta-analysis. Ann Med Surg (Lond). 2022 Aug;80:104281. doi: 10.1016/j.amsu.2022.104281. Epub 2022 Aug 8.

534. G De Luca, A Silverio, M Verdoia et al. Angiographic and clinical outcome of SARS-CoV-2 positive patients with ST-segment elevation myocardial infarction undergoing primary angioplasty: A collaborative, individual patient data meta-analysis of six registry-based studies. Eur J Intern Med. 2022 Nov;105:69—76. doi: 10.1016/j. ejim.2022.08.021. Epub 2022 Aug 18.

535. C-P Yang, C-M Chang, C-C Yang et al. Long COVID and long chain fatty acids (LCFAs): Psychoneuroimmunity implication of omega-3 LCFAs in delayed consequences of COVID-19. Brain Behav Immun. 2022 Jul;103:19—27. doi: 10.1016/j.bbi.2022.04.001. Epub 2022 Apr 4.

536. D K Bonilla-Aldana, A García-Barco, S D Jimenez-Diaz et al. SARS-CoV-2 natural infection in animals: a systematic review of studies and case reports and series. Vet Q. 2021 Dec;41 (1):250—267. doi: 10.1080/01652176.2021.1970280.

537. F Ashra, R Chen, X L Kang et al. Effectiveness of prone position in acute respiratory distress syndrome and moderating factors of obesity class and treatment durations for COVID-19 patients: A meta-analysis. Intensive Crit Care Nurs. 2022 Oct;72:103257. doi: 10.1016/j. iccn.2022.103257. Epub 2022 Apr 11.

538. M Rostami, H Mansouritorghabeh, M Parsa-Kondelaji. High levels of Von Willebrand factor markers in COVID-19: a systematic review and meta-analysis. Clin Exp Med. 2022 Aug;22 (3):347—357. doi: 10.1007/s10238-021-00769-x. Epub 2021 Nov 6.

539. M Wrona, D Skrypnik. New-Onset Diabetes Mellitus, Hypertension, Dyslipidaemia as Sequelae of COVID-19 Infection-Systematic Review. Int J Environ Res Public Health. 2022 Oct 14;19 (20):13280. doi: 10.3390/ijerph192013280.

540. O R Alzahrani, A D Alanazi, Y M Hawsawi. Gastrointestinal manifestations of COVID-19: An updated systematic review. Trop Biomed.2022 Sep 1;39 (3):428—433. doi: 10.47665/tb.39.3.013.

541. A Watanabe, M So, M Iwagami et al. One-year follow-up CT findings in COVID-19 patients: A systematic review and meta-analysisRespirology. 2022 Aug;27 (8):605—616. doi: 10.1111/resp.14311. Epub 2022 Jun 12.

542. A Otunla, K Rees, P Dennison et al. Risks of infection, hospital and ICU admission, and death from COVID-19 in people with asthma: systematic review and meta-analyses. BMJ Evid Based Med. 2022 Oct;27 (5):263—273. doi: 10.1136/bmjebm-2021-111788. Epub 2021 Dec 21.

543. Y Ji, Y Fang, B Cheng et al. Tracheostomy timing and clinical outcomes in ventilated COVID-19 patients: a systematic review and meta-analysisCrit Care. 2022 Feb 8;26 (1):40. doi: 10.1186/s13054-022-03904-6.

544. A Petrov, J P De Glee Romera, M Wilbring et al. Aortic Thrombosis following COVID-19: A Systematic Review. Thorac Cardiovasc Surg. 2022 Jun;70 (4):323—332. doi: 10.1055/s-0041-1740554. Epub 2022 Feb 2.

545. H Lobbes, S Mainbourg, V Mai et al. Risk Factors for Venous Thromboembolism in Severe COVID-19: A Study-Level Meta-Analysis of 21 Studies. Int J Environ Res Public Health. 2021 Dec 8;18 (24):12944. doi: 10.3390/ijerph182412944.

546. M J Abrahão Silva, L R Ribeiro, K V Batista Lima et al. Adaptive immunity to SARS-CoV-2 infection: A systematic review. Front Immunol. 2022 Oct 10;13:1001198. doi: 10.3389/fimmu.2022.1001198. eCollection 2022.

547. A Cereda, L Allievi, A Palmisano et al. Systematic review and meta-analysis on coronary calcifications in COVID-19. Emerg Radiol. 2022 Aug;29 (4):631—643. doi: 10.1007/s10140-022-02048-y. Epub 2022 Apr 30.

548. M Zuin, G Rigatelli, V Battisti et al. Increased risk of acute myocardial infarction after COVID-19 recovery: A systematic review and meta-analysis.Int J Cardiol. 2023 Feb 1;372:138—143. doi: 10.1016/j. ijcard.2022.12.032. Epub 2022 Dec 16.

549. Sandra Lopez-Leon, T Wegman-Ostrosky, N C A Del Valle et al. Long-COVID in children and adolescents: a systematic review and meta-analyses. Sci Rep. 2022 Jun 23;12 (1):9950. doi: 10.1038/s41598-022-13495-5.

550. A Haghpanah, F Masjedi, M Salehipour et al. Is COVID-19 a risk factor for progression of benign prostatic hyperplasia and exacerbation of its related symptoms?: a systematic review. Prostate Cancer Prostatic Dis. 2022 Mar;25 (1):27—38. doi: 10.1038/s41391-021-00388-3. Epub 2021 May 18.

551. J Xiong, J Li, X Wu et al. The association between daily-diagnosed COVID-19 morbidity and short-term exposure to PM1 is larger than associations with PM2.5 and PM10. Environ Res. 2022 Jul;210:113016. doi: 10.1016/j. envres.2022.113016. Epub 2022 Feb 24.

552. A Weiss, M Jellingsø, M O A Sommer. Spatial and temporal dynamics of SARS-CoV-2 in COVID-19 patients: A systematic review and meta-analysis. EBioMedicine. 2020 Aug;58:102916. doi: 10.1016/j. ebiom.2020.102916. Epub 2020 Jul 22.